Comparison of First-Line Treatment with Bendamustine Plus Rituximab Versus R-CHOP for Patients with Follicular Lymphoma Grade 3A: Results of a Retrospective Study from the Fondazione Italiana Linfomi
FRONTIERS IN ONCOLOGY(2023)
Key words
follicular lymphoma,grade 3A,bendamustine,CHOP,rituximab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined